BridgeBio Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on February 20, 2025

Core Insights - BridgeBio Pharma, Inc. is set to report its financial results for Q4 and the full year of 2024 on February 20, 2025, along with updates on Attruby's commercialization and its late-stage clinical pipeline [1] - The company plans to start hosting earnings calls with the Q1 earnings release, anticipated in late April or early May [2] - Founded in 2015, BridgeBio focuses on discovering and delivering transformative medicines for genetic diseases, with a pipeline that spans from early science to advanced clinical trials [3]